Research by Cui et al. discusses the role of various oncogenes and tumor suppressor genes in NSCLC, including mutations in EGFR, K-RAS, and p53, which are critical in cancer pathways. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.